259 related articles for article (PubMed ID: 22528765)
1. Therapeutic options for low bone mineral density in HIV-infected subjects.
Cotter AG; Mallon PW
Curr HIV/AIDS Rep; 2012 Jun; 9(2):148-59. PubMed ID: 22528765
[TBL] [Abstract][Full Text] [Related]
2. Management of bone mineral density in HIV-infected patients.
Negredo E; Bonjoch A; Clotet B
Expert Opin Pharmacother; 2016; 17(6):845-52. PubMed ID: 26809940
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Stable Bone Mineral Density in HIV-Infected Men Without Risk Factors for Osteoporosis Treated with Antiretroviral Therapy.
Bolland MJ; Horne AM; Briggs SE; Thomas MG; Reid IR; Gamble GD; Grey A
Calcif Tissue Int; 2019 Oct; 105(4):423-429. PubMed ID: 31250043
[TBL] [Abstract][Full Text] [Related]
4. HIV infection and bone disease: implications for an aging population.
Cotter AG; Mallon PW
Sex Health; 2011 Dec; 8(4):493-501. PubMed ID: 22127034
[TBL] [Abstract][Full Text] [Related]
5. Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120).
Rozenberg S; Lanoy E; Bentata M; Viard JP; Valantin MA; Missy P; Darasteanu I; Roux C; Kolta S; Costagliola D;
AIDS Res Hum Retroviruses; 2012 Sep; 28(9):972-80. PubMed ID: 22353022
[TBL] [Abstract][Full Text] [Related]
6. Interventions for the treatment of decreased bone mineral density associated with HIV infection.
Lin D; Rieder MJ
Cochrane Database Syst Rev; 2007 Apr; (2):CD005645. PubMed ID: 17443607
[TBL] [Abstract][Full Text] [Related]
7. Bone health in HIV infection.
Pollock E; Klotsas AE; Compston J; Gkrania-Klotsas E
Br Med Bull; 2009; 92():123-33. PubMed ID: 19875393
[TBL] [Abstract][Full Text] [Related]
8. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
[TBL] [Abstract][Full Text] [Related]
9. Bone changes and fracture risk in individuals infected with HIV.
Warriner AH; Mugavero MJ
Curr Rheumatol Rep; 2010 Jun; 12(3):163-9. PubMed ID: 20425517
[TBL] [Abstract][Full Text] [Related]
10. CD4 T cell count is inversely associated with lumbar spine bone mass in HIV-infected men under the age of 50 years.
Kwak MK; Lee EJ; Park JW; Park SY; Kim B-; Kim TH; Suh K; Koh J-; Lee SH; Byun D-
Osteoporos Int; 2019 Jul; 30(7):1501-1510. PubMed ID: 30915506
[TBL] [Abstract][Full Text] [Related]
11. Bone loss in patients with HIV infection.
Paccou J; Viget N; Legrout-Gérot I; Yazdanpanah Y; Cortet B
Joint Bone Spine; 2009 Dec; 76(6):637-41. PubMed ID: 19945322
[TBL] [Abstract][Full Text] [Related]
12. High Prevalence of Low Bone Mineral Density and Substantial Bone Loss over 4 Years Among HIV-Infected Persons in the Era of Modern Antiretroviral Therapy.
Escota GV; Mondy K; Bush T; Conley L; Brooks JT; Önen N; Patel P; Kojic EM; Henry K; Hammer J; Wood KC; Lichtenstein KA; Overton ET
AIDS Res Hum Retroviruses; 2016 Jan; 32(1):59-67. PubMed ID: 26366785
[TBL] [Abstract][Full Text] [Related]
13. Protecting bone in long-term HIV positive patients receiving antiretrovirals.
McGinty T; Mallon P
Expert Rev Anti Infect Ther; 2016 Jun; 14(6):587-99. PubMed ID: 27189695
[TBL] [Abstract][Full Text] [Related]
14. Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors.
Goh SSL; Lai PSM; Tan ATB; Ponnampalavanar S
Osteoporos Int; 2018 Mar; 29(3):595-613. PubMed ID: 29159533
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density loss, osteoporosis, and fractures in HIV.
Labarga P
AIDS Rev; 2013; 15(3):189-90. PubMed ID: 24002203
[TBL] [Abstract][Full Text] [Related]
16. Alveolar bone in human immunodeficiency virus infection: is it changed by long-term antiretroviral therapy?
Nittayananta W; Kanjanaprapas A; Arirachakaran P; Pangsomboon K; Sriplung H
Int Dent J; 2017 Apr; 67(2):123-129. PubMed ID: 27864831
[TBL] [Abstract][Full Text] [Related]
17. Bone alterations associated with HIV.
Warriner AH; Mugavero M; Overton ET
Curr HIV/AIDS Rep; 2014 Sep; 11(3):233-40. PubMed ID: 25064454
[TBL] [Abstract][Full Text] [Related]
18. Bone loss in the HIV-infected patient: evidence, clinical implications, and treatment strategies.
Walker Harris V; Brown TT
J Infect Dis; 2012 Jun; 205 Suppl 3(Suppl 3):S391-8. PubMed ID: 22577213
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral density in HIV-infected women taking antiretroviral therapy: a systematic review.
Carvalho EH; Gelenske T; Bandeira F; Albuquerque Mda F
Arq Bras Endocrinol Metabol; 2010 Mar; 54(2):133-42. PubMed ID: 20485901
[TBL] [Abstract][Full Text] [Related]
20. Osteoporosis and bone health in HIV.
Powderly WG
Curr HIV/AIDS Rep; 2012 Sep; 9(3):218-22. PubMed ID: 22581359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
